Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Saccharomyces boulardii in Helicobacter pylori Eradication
NCT03688828Completed
- Sponsor
- Huazhong University of Science and Technology
- Start
- Nov 2018
- Primary completion
- Jun 2020
- Modality
- Microbiome Therapeutics
- Countries
- 1
01
Overview
Randomised, open-label trial of saccharomyces boulardii in Helicobacter pylori infection, sponsored by Huazhong University of Science and Technology. Started Nov 2018; status: completed.
02
Drugs
saccharomyces boulardii
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT03688828.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03688828.